Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3003
Clinical trial NCT02289716 · COMPLETED
Trial details
- NCT number
- NCT02289716
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-10
- Primary completion
- 2016-10-10
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.